Literature DB >> 26494402

Stenting for acute cerebral venous sinus thrombosis in the superior sagittal sinus.

Hidemitsu Adachi1, Yohei Mineharu2, Tatsuya Ishikawa3, Hirotoshi Imamura3, Shiro Yamamoto3, Kenichi Todo3, Hiroshi Yamagami4, Nobuyuki Sakai2.   

Abstract

Endovascular treatment for superior sagittal sinus (SSS) thrombosis is not always successful because of difficult access and long thrombus lesions. We report the first two cases of patients with acute cerebral venous sinus thrombosis at the SSS that was not recanalized by anticoagulation, mechanical thrombectomy, or thrombolysis, but was successfully treated by stent placement. Case 1 was a 37-year-old woman with bilateral subdural hematomas. Digital subtraction angiography showed obstruction of the sinus from the SSS to the right transverse sinus. Recanalization was achieved by selective thrombolysis using urokinase followed by balloon angioplasty, but re-occlusion occurred on the next day of treatment. Repeated endovascular treatment including balloon angioplasty, thrombus aspiration and thrombolysis using recombinant tissue plasminogen activator failed to achieve recanalization. We thus placed intracranial stents in the SSS, which did achieve recanalization. Case 2 was a 69-year-old woman with a small infarction in the left parietal lobe. Digital subtraction angiography showed sinus obliteration from the SSS to the bilateral transverse sinuses. Recanalization was not achieved by balloon angioplasty, thrombus aspiration and selective thrombolysis. We thus placed intracranial stents in the SSS, which did achieve recanalization. Postoperative course was uneventful in both cases and venous sinus patency was confirmed by venography >1.5 years after treatment. When conventional endovascular strategies have been unsuccessful, placement of intracranial stents, which can easily gain access to the distal part of the SSS as compared with carotid stents, may be a useful treatment option for the acute sinus thrombosis in this region.
© The Author(s) 2015.

Entities:  

Keywords:  Superior sagittal sinus; endovascular treatment; intracranial stent; sinus thrombosis; venous thrombosis

Mesh:

Substances:

Year:  2015        PMID: 26494402      PMCID: PMC4757359          DOI: 10.1177/1591019915609120

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  16 in total

1.  Rheolytic catheter thrombectomy, balloon angioplasty, and direct recombinant tissue plasminogen activator thrombolysis of dural sinus thrombosis with preexisting hemorrhagic infarctions.

Authors:  Kenneth R Curtin; Ali Shaibani; Scott A Resnick; Eric J Russell; Tanya Simuni
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

2.  Use of a self-expanding stent with balloon angioplasty in the treatment of dural arteriovenous fistulas involving the transverse and/or sigmoid sinus: functional and neuroimaging-based outcome in 10 patients.

Authors:  Olivier Levrier; Philippe Métellus; Stephane Fuentes; Luis Manera; Henry Dufour; Anne Donnet; François Grisoli; Jean-Michel Bartoli; Nadine Girard
Journal:  J Neurosurg       Date:  2006-02       Impact factor: 5.115

3.  Use of mechanical thrombolysis via microballoon percutaneous transluminal angioplasty for the treatment of acute dural sinus thrombosis: case presentation and technical report.

Authors:  J C Chaloupka; S Mangla; D C Huddle
Journal:  Neurosurgery       Date:  1999-09       Impact factor: 4.654

4.  Heparin treatment in sinus venous thrombosis.

Authors:  K M Einhäupl; A Villringer; W Meister; S Mehraein; C Garner; M Pellkofer; R L Haberl; H W Pfister; P Schmiedek
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

5.  Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis.

Authors:  M Wasay; R Bakshi; S Kojan; G Bobustuc; N Dubey; D H Unwin
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

6.  Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis.

Authors:  S F de Bruijn; J Stam
Journal:  Stroke       Date:  1999-03       Impact factor: 7.914

7.  Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: a prospective study.

Authors:  Jan Stam; Charles B L M Majoie; Otto M van Delden; Krijn P van Lienden; Jim A Reekers
Journal:  Stroke       Date:  2008-03-13       Impact factor: 7.914

8.  Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).

Authors:  José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2004-02-19       Impact factor: 7.914

9.  Endovascular recanalization with balloon angioplasty and stenting of an occluded occipital sinus for treatment of intracranial venous hypertension: technical case report.

Authors:  A M Malek; R T Higashida; P A Balousek; C C Phatouros; W S Smith; C F Dowd; V V Halbach
Journal:  Neurosurgery       Date:  1999-04       Impact factor: 4.654

10.  Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension.

Authors:  Ahmet Arac; Marco Lee; Gary K Steinberg; Mary Marcellus; Michael P Marks
Journal:  Neurosurg Focus       Date:  2009-11       Impact factor: 4.047

View more
  8 in total

1.  Stenting of symptomatic lateral sinus thrombosis refractory to mechanical thrombectomy.

Authors:  Guangdong Lu; Jae Ho Shin; Yunsun Song; Deok Hee Lee
Journal:  Interv Neuroradiol       Date:  2019-05-27       Impact factor: 1.610

2.  A case of stenting for acute cerebral venous sinus thrombosis in the superior sagittal sinus.

Authors:  Naoki Matsumoto; Yoji Kuramoto; Narihide Shinoda; Yasushi Ueno
Journal:  Interv Neuroradiol       Date:  2016-08-17       Impact factor: 1.610

3.  Epidemiology of Isolated Versus Nonisolated Mild Traumatic Brain Injury Treated in Emergency Departments in the United States, 2006-2012: Sociodemographic Characteristics.

Authors:  Carol Cancelliere; Victor G Coronado; Christopher A Taylor; Likang Xu
Journal:  J Head Trauma Rehabil       Date:  2017 Jul/Aug       Impact factor: 2.710

4.  Cerebral venous sinuses thrombosis in both transverse sinus and torcula: Multistep endovascular treatment and stenting.

Authors:  G Cabral de Andrade; A Lesczynsky; V M Clímaco; E R Pereira; P O Marcelino; Aoc Franco; D F De Almeida
Journal:  Interv Neuroradiol       Date:  2016-10-27       Impact factor: 1.610

5.  Successful presurgical endovascular management of venous sinus thrombosis associated with high-grade cerebral arteriovenous malformation: A case report.

Authors:  Yoshinari Osada; Hidenori Endo; Kenichi Sato; Yasushi Matsumoto; Toshiki Endo; Miki Fujimura; Teiji Tominaga
Journal:  Interv Neuroradiol       Date:  2017-09-11       Impact factor: 1.610

6.  Endovascular treatment for hemorrhagic cerebral venous sinus thrombosis: experience with 9 cases for 3 years.

Authors:  Shizhong Zhang; Yanyan Hu; Zhen Li; Dezhang Huang; Mingran Zhang; Chenglong Wang; Zhigang Wang
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

7.  High-Risk Features of Delayed Clinical Progression in Cerebral Venous Thrombosis: A Proposed Prediction Score for Early Intervention.

Authors:  Saif A Bushnaq; Fares Qeadan; Tapan Thacker; Mohammad Abbas; Andrew P Carlson
Journal:  Interv Neurol       Date:  2018-04-20

Review 8.  Endovascular Treatment of Intracranial Vein and Venous Sinus Thrombosis-A Systematic Review.

Authors:  Philipp Bücke; Victoria Hellstern; Alexandru Cimpoca; José E Cohen; Thomas Horvath; Oliver Ganslandt; Hansjörg Bäzner; Hans Henkes
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.